ERCC4 and xeroderma pigmentosum: To date, all previously published ERCC4/XPF pathogenic variants have been identified in the exons, and with a limited number of variants resulting in devastating XFE and COFS, most of the pathogenic mutations are hypomorphic changes causing only mild XP clinical manifestations (31).